Literature DB >> 19910418

Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT.

Yong-An Chung1, Joo Hyun O, Jee-Young Kim, Ki-Jun Kim, Kook-Jin Ahn.   

Abstract

UNLABELLED: Cerebral amyloid angiopathy (CAA) is known to be an important cause of spontaneous cortical-subcortical intracranial hemorrhage in normotensive older persons. CAA can also manifest as leukoencephalopathy, brain atrophy, and ischemia secondary to hypoperfusion. Our goal was to verify cerebral hypoperfusion in patients with CAA using (99m)Tc-ethylcysteinate dimer ((99m)Tc-ECD) brain perfusion SPECT.
METHODS: A total of 11 patients (5 men and 6 women; age range, 58-78 y; mean age +/- SD, 70.0 +/- 7.0 y) with clinically and radiologically established probable CAA who underwent (99m)Tc-ECD SPECT were included. (99m)Tc-ECD SPECT scans were also obtained from 13 age-matched healthy control subjects (7 men and 6 women; age range, 60-79 y; mean age +/- SD, 66.7 +/- 6.4 y) for comparison. The relative regional cerebral blood flow values obtained for patients and controls were compared using software.
RESULTS: Compared with controls, patients with probable CAA showed hypoperfusion in the inferior parietal lobule of both parietal lobes (Brodmann area [BA] 40), middle temporal gyrus of the left temporal lobe (BA 39), postcentral gyrus of the right parietal lobe, superior temporal gyrus of the right temporal lobe (BA 22), superior temporal gyrus of the right frontal lobe (BA 10), inferior temporal gyrus of the left temporal lobe (BA 20), and both caudate bodies (P < 0.0001, t = 4.65).
CONCLUSION: Patients with probable CAA had significantly decreased cerebral perfusion and may be at risk for leukoencephalopathy, atrophy, and ischemia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910418     DOI: 10.2967/jnumed.109.062315

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  23 in total

1.  Delivery of Polymeric Nanoparticles to Target Vascular Diseases.

Authors:  Edward Agyare; Karunyna Kandimalla
Journal:  J Biomol Res Ther       Date:  2014-01

2.  Non-amyloid and amyloid prion protein deposits in prion-infected mice differ in blockage of interstitial brain fluid.

Authors:  A Rangel; B Race; J Striebel; B Chesebro
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

Review 3.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

4.  Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study.

Authors:  Anna M van Opstal; Sanneke van Rooden; Thijs van Harten; Eidrees Ghariq; Gerda Labadie; Panagiotis Fotiadis; M Edip Gurol; Gisela M Terwindt; Marieke J H Wermer; Mark A van Buchem; Steven M Greenberg; Jeroen van der Grond
Journal:  Lancet Neurol       Date:  2016-12-16       Impact factor: 44.182

5.  Incidental Cerebral Microbleeds and Cerebral Blood Flow in Elderly Individuals.

Authors:  Nicholas M Gregg; Albert E Kim; M Edip Gurol; Oscar L Lopez; Howard J Aizenstein; Julie C Price; Chester A Mathis; Jeffrey A James; Beth E Snitz; Ann D Cohen; M Ilyas Kamboh; Davneet Minhas; Lisa A Weissfeld; Erica L Tamburo; William E Klunk
Journal:  JAMA Neurol       Date:  2015-09       Impact factor: 18.302

6.  Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults.

Authors:  Robert J Dawe; Lei Yu; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Patricia A Boyle
Journal:  Neurobiol Aging       Date:  2018-05-23       Impact factor: 4.673

Review 7.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

8.  Neuropathologic basis of age-associated brain atrophy.

Authors:  Deniz Erten-Lyons; Hiroko H Dodge; Randall Woltjer; Lisa C Silbert; Diane B Howieson; Patricia Kramer; Jeffrey A Kaye
Journal:  JAMA Neurol       Date:  2013-05       Impact factor: 18.302

9.  Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.

Authors:  Xiayoue Zhu; Tiffany W Victor; Ashwin Ambi; Joseph K Sullivan; Joshua Hatfield; Feng Xu; Lisa M Miller; William E Van Nostrand
Journal:  Metallomics       Date:  2020-02-27       Impact factor: 4.526

Review 10.  Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.

Authors:  Oliver Bracko; Jean C Cruz Hernández; Laibaik Park; Nozomi Nishimura; Chris B Schaffer
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.